Home > Drug Search >
  • company_query: Altor BioScience Corporation
  •   > 
Drug Filter
Category:
chemistry (4) biology (26)
Status:
Approved (5) Phase Ⅲ (3) Phase Ⅱ (12) Phase Ⅰ (9) IND Filing (1)
Clinical Stage:
Pending (3) Active (19) Discontinued (2)
Bio-Type:
Oncolytic virus (2) Vaccine (2) Recombinant hormone/Synthetic peptide (1) Recombinant enzyme (1) Recombinant cytokines (2) Recombinant hormone (1) Whole antibody (5) ADC (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Anemia (1) Atopic dermatitis (1) Bladder cancer (2) Cutaneous T cell lymphoma (CTCL) (1) Rheumatic disorders (1) Urogenital cancer (1) Alcoholic hepatitis (1) Somatotropin deficiency (1) Lung cancer (1) Lymphoma (1) Melanoma (2) Haematological disorders (1) Multiple myeloma (MM) (2) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (2) Pancreatic cancer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (3) Solid tumours (3) Systemic lupus erythematosus (1) Nasopharyngeal cancer (1) Cervical intraepithelial neoplasia (1) Fabry disease (1) Colorectal cancer (1) Cryopyrin-Associated Periodic Syndromes (CAPS) (1) Ankylosing Spondylitis (AS) (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Neuroblastoma (1) Pain (1) Autistic disorder (1) Diabetes (1) Neutropenia (1) Hyperphosphatemia (1) Infertility (1) Autoimmune diseases (1) Plaque psoriasis (2) Inflammation (1) Human papillomavirus infections (HPV) (1) Immune thrombocytopenic purpura (1) Hypersensitivity (1)
Country:
Aprv. Year:
2006 (1) 2010 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top